Pharmaceuticals
Drug CRO Medpace to be sold to European PE firm Cinven for $915 mn
25 Feb 2014
European buyout firm Cinven Ltd yesterday confirmed that it will acquire pharmaceutical contract research company Medpace Inc for $915 million from CCMP Capital Advisor
Bayer close to bagging cancer drug maker Algeta for $2.9-bn
24 Feb 2014
German healthcare major Bayer AG today said that it is close to completing its $2.9-billion acquisition of Algeta, after 92.17 per cent shareholders of the Norwegian cancer drug maker tendered their shares to the offer
